Sat.Dec 15, 2018 - Fri.Dec 21, 2018

Remove blogging-capital
article thumbnail

$100M Round Turns San Diego’s Seismic into Region’s Newest Unicorn

Xconomy

Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors.

article thumbnail

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

Xconomy

Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 RiverVest Venture Partners, a St. million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices.

San Diego 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca

Xconomy

A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche , Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies.

article thumbnail

San Diego Tallies 7 IPOs in Best Year For Market Debuts Since 2014

Xconomy

Will “CBUS” and “SI” join “THOR” and “RMED”? It’s next week or never (until 2019, that is) for two San Diego companies that have filed documents with securities regulators indicating plans to go public.

article thumbnail

Graphcore Scores $200M to Scale Up A.I. Chip Production

Xconomy

The Bristol, UK-based startup, founded in 2016, has now secured a total of more than $300 million in financing from venture capital firms and other investors including Microsoft and the corporate venture arms of BMW and Dell Technologies. One of the leading contenders in the A.I.

article thumbnail

Aristea Therapeutics Raises $15M to Develop Anti-Inflammatory Drugs

Xconomy

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67
article thumbnail

Cisco to Pay $660M for Luxtera, Maker of Advanced Data Center Chips

Xconomy

Cisco has agreed to pay $660 million for Luxtera, a Caltech spinout that makes optical chips for data centers. The semiconductor company, founded in 2001, is based in Carlsbad, CA, a San Diego suburb.